Axinn Earns Top Antitrust Rankings Coast to Coast in GCR 100
December 17, 2025
Axinn is pleased to announce that its Antitrust practice has once again been recognized as one of the leading antitrust practices globally in Global Competition Review’s 2026 GCR 100. This year’s rankings highlight the firm’s continued strength and expanding footprint across key U.S. markets.
Global Competition Review ranked Axinn’s New York Antitrust practice as “Elite” and its Washington, DC Antitrust practice as “Highly Recommended.” In addition, Axinn’s California Antitrust practice was “Recommended,” underscoring the firm’s growing presence on the West Coast and its expanding role in major technology and healthcare/life sciences competition matters.
The GCR 100 is a comprehensive, independent assessment of the world’s leading antitrust and competition practices, providing in-depth qualitative analysis of top firms across jurisdictions worldwide.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth—always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust